Cover Image
市場調查報告書

葡萄糖生物感應器市場規模與預測:各終端用戶 (醫院、居家醫療診斷、研究機關、診斷中心、診療所) 、各地區 (美國、英國、德國、中國、印度、巴西、沙烏地阿拉伯、南非) 及2015∼2022年趨勢分析

Glucose Biosensor Market Size & Forecast By End-use (Hospitals, Homecare Diagnostics, Research Institutes, Diagnostic Centers, Clinics), By Region (U.S., UK, Germany, China, India, Brazil, Saudi Arabia, South Africa) And Trend Analysis From 2015 To 2022

出版商 Grand View Research, Inc. 商品編碼 355249
出版日期 內容資訊 英文 89 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
葡萄糖生物感應器市場規模與預測:各終端用戶 (醫院、居家醫療診斷、研究機關、診斷中心、診療所) 、各地區 (美國、英國、德國、中國、印度、巴西、沙烏地阿拉伯、南非) 及2015∼2022年趨勢分析 Glucose Biosensor Market Size & Forecast By End-use (Hospitals, Homecare Diagnostics, Research Institutes, Diagnostic Centers, Clinics), By Region (U.S., UK, Germany, China, India, Brazil, Saudi Arabia, South Africa) And Trend Analysis From 2015 To 2022
出版日期: 2016年02月22日 內容資訊: 英文 89 Pages
簡介

全球葡萄糖生物感應器市場,預計至2022年達到310億美元。支持該成長的是,全球的糖尿病發病率的上升和技術性進化的產品的開發,微創或非侵入性產品的需求擴大,患者的認知度,對糖尿病的早期發現的需求等。

本報告提供全球葡萄糖生物感應器市場現狀與至2022年的成長預測,各終端用戶,各地區趨勢,以及主要企業的簡介等彙整。

第1章 調查方法與調查範圍

第2章 摘要整理

第3章 產業預測

  • 市場區隔
  • 市場規模與成長預測
  • 葡萄糖生物感應器:市場趨勢
    • 促進要素
    • 阻礙要素
  • 產業趨勢分析
  • PESTEL分析
  • 產業分析:波特
  • 市場佔有率分析
  • 主要的機會

第4章 各終端用戶市場預測

  • 各終端用戶收益佔有率分析
  • 醫院
  • 居家醫療診斷
  • 其他

第5章 各地區預測

  • 各地區市場佔有率
  • 北美
  • 歐洲
  • 亞太地區
  • 中東、非洲
  • 南美

第6章 競爭環境

  • Roche Diagnostics
  • LifeScan Inc.
  • Abbott Laboratories
  • Bayer
  • Medtronic Inc.
  • Pinnacle Medical Solutions Inc.
  • AgaMatrix Inc.
  • Sanofi S.A.
  • BioSense Medical Devices, LLC
  • Nova Biomedical

圖表

目錄
Product Code: 978-1-68038-739-1

Global Glucose Biosensor Market is expected to reach USD 31.0 billion by 2022, according to a new report by Grand View Research Inc. The global Glucose Biosensor Market is anticipated to witness lucrative growth during the period of 2015 to 2022.

Some key factors attributing to the growth of this market include the increasing incidence of diabetes across the globe, development of technologically advanced products, growing demand for minimally and non-invasive products, patient awareness levels, and the need for early diabetes detection. However, presence of other alternatives for management of the diabetes, such as laboratory methods is expected to restrict market growth.

The glucose biosensors industry by end-use is segmented on the basis of its use in hospitals, homecare diagnostics, and others including research institutes, diagnostics, and clinical laboratories. The homecare diagnostics Glucose Biosensor Market is projected to flourish over the forecast period. Ease-of-use, quick results, and low costs of the tests are some aspects supporting market growth. On the other hand, the hospital-based Glucose Biosensor Market is projected to grow at a significant CAGR of 10.3% during the period 2015 to 2022.

Further key findings from the study suggest:

North America led the market, in terms of value, with a share of about 37% in 2015. High disease burden and the subsequent need to curb associated healthcare expenditure in the U.S., has resulted in this country account for a large revenue share of the North American market in 2014. According to the Centers of Disease Control (CDC), around 22.3 million people in the U.S. were estimated to be diagnosed with diabetes in the year 2013.

Asia Pacific is anticipated to witness lucrative growth during the forecast period. This market is projected to grow rapidly during the period 2015 to 2022. China and India are expected to spearhead market growth in this region.

The homecare diagnostics Glucose Biosensor Market was the largest in 2014. The segment is anticipated to grow at a rapid CAGR during the forecast period. As of 2015, the market was led by North America owing to the region's highest disease burden and homecare diagnostics adoption rates.

The Glucose Biosensor Market comprises several local as well as global players. Some major players of this industry include Roche, Bayer and LifeScan, Inc..

Table of Content

Chapter 1. Methodology and Scope

  • 1.1. Research methodology
  • 1.2. Research scope & assumption
  • 1.3. List of data sources

Chapter 2. Executive Summary

  • 2.1. Glucose biosensors Market - Industry Summary and Key Buying Criteria, 2012 - 2020

Chapter 3. Glucose biosensors Industry Outlook

  • 3.1. Market segmentation
  • 3.2. Market size and growth prospects, 2012-2020
  • 3.3. Glucose biosensors: Market dynamics
    • 3.3.1. Market driver analysis
      • 3.3.1.1. Rising prevalence of diabetes
      • 3.3.1.2. Presence of a strong range of products in pipeline
      • 3.3.1.3. Growing prevalence of lifestyle induced disorders such as obesity
    • 3.3.2. Market restraint analysis
      • 3.3.2.1. Presence of alternative methods
  • 3.4. Glucose biosensors market: Industry trend analysis
  • 3.5. Glucose biosensors Market - PESTEL Analysis
  • 3.6. Glucose biosensors Industry analysis - Porter's Five Forces Model
  • 3.7. Glucose biosensors: Company Market Share Analysis (%), 2014
  • 3.8. Key opportunities prioritized

Chapter 4. Glucose Biosensors End-User Application Outlook

  • 4.1. Glucose Biosensors Revenue Share (%) Analysis, by End-User Application, 2014 & 2022
  • 4.2. Hospital
    • 4.2.1. Hospital market revenue, by region, 2012 to 2022 (USD Million)
  • 4.3. Homecare Diagnostics
    • 4.3.1. Homecare diagnostics market revenue, by region, 2012 to 2022 (USD Million)
  • 4.4. Others
    • 4.4.1. Others market revenue, by region, 2012 to 2022 (USD Million)

Chapter 5. Glucose Biosensors Regional Outlook

  • 5.1. Glucose Biosensors Market Share (%) Analysis, by Region, 2014 & 2022
  • 5.2. North America
    • 5.2.1. U.S.
      • 5.2.1.1. Glucose biosensors market, by end-user application, 2012 - 2022 (USD Million)
    • 5.2.2. Canada
      • 5.2.2.1. Glucose biosensors market, by end-user application, 2012 - 2022 (USD Million)
  • 5.3. Europe
    • 5.3.1. Germany
      • 5.3.1.1. glucose biosensors market, by end-user application, 2012 - 2022 (USD Million)
    • 5.3.2. U.K.
      • 5.3.2.1. Glucose biosensors market, by end-user application, 2012 - 2022 (USD Million)
    • 5.3.3. Rest of Europe
      • 5.3.3.1. Glucose biosensors market, by end-user application, 2012 - 2022 (USD Million)
  • 5.4. Asia Pacific
    • 5.4.1. China
      • 5.4.1.1. Glucose biosensors market, by end-user application, 2012 - 2022 (USD Million)
    • 5.4.2. India
      • 5.4.2.1. Glucose biosensors market, by end-user application, 2012 - 2022 (USD Million)
    • 5.4.3. Rest of Asia Pacific
      • 5.4.3.1. Glucose biosensors market, by end-user application, 2012 - 2022 (USD Million)
  • 5.5. MEA
    • 5.5.1. South Africa
      • 5.5.1.1. Glucose biosensors market, by end-user application, 2012 - 2022 (USD Million)
    • 5.5.2. Saudi Arabia
      • 5.5.2.1. Glucose biosensors market, by end-user application, 2012 - 2022 (USD Million)
    • 5.5.3. Rest of MEA
      • 5.5.3.1. Glucose biosensors market, by end-user application, 2012 - 2022 (USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Glucose biosensors market, by end-user application, 2012 - 2022 (USD Million)
    • 5.6.2. Mexico
      • 5.6.2.1. Glucose biosensors market, by end-user application, 2012 - 2022 (USD Million)
    • 5.6.3. Rest of Latin America
      • 5.6.3.1. Glucose biosensors market, by end-user application, 2012 - 2022 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Roche Diagnostics
    • 6.1.1. Company Overview
    • 6.1.2. Financial Performance
    • 6.1.3. Product Benchmarking
    • 6.1.4. Strategic Initiatives
  • 6.2. LifeScan Inc.
    • 6.2.1. Company Overview
    • 6.2.2. Financial Performance
    • 6.2.3. Product Benchmarking
    • 6.2.4. Strategic Initiatives
  • 6.3. Abbott Laboratories
    • 6.3.1. Company Overview
    • 6.3.2. Financial Performance
    • 6.3.3. Product Benchmarking
    • 6.3.4. Strategic Initiatives
  • 6.4. Bayer
    • 6.4.1. Company Overview
    • 6.4.2. Financial Performance
    • 6.4.3. Product Benchmarking
    • 6.4.4. Strategic Initiatives
  • 6.5. Medtronic Inc.
    • 6.5.1. Company Overview
    • 6.5.2. Financial Performance
    • 6.5.3. Product Benchmarking
    • 6.5.4. Strategic Initiatives
  • 6.6. Pinnacle Medical Solutions Inc.
    • 6.6.1. Company Overview
    • 6.6.2. Financial Performance
    • 6.6.3. Product Benchmarking
    • 6.6.4. Strategic Initiatives
  • 6.7. AgaMatrix Inc.
    • 6.7.1. Company Overview
    • 6.7.2. Financial Performance
    • 6.7.3. Product Benchmarking
    • 6.7.4. Strategic Initiatives
  • 6.8. Sanofi S.A.
    • 6.8.1. Company Overview
    • 6.8.2. Financial Performance
    • 6.8.3. Product Benchmarking
    • 6.8.4. Strategic Initiatives
  • 6.9. BioSense Medical Devices, LLC
    • 6.9.1. Company Overview
    • 6.9.2. Financial Performance
    • 6.9.3. Product Benchmarking
    • 6.9.4. Strategic Initiatives
  • 6.10. Nova Biomedical
    • 6.10.1. Company Overview
    • 6.10.2. Financial Performance
    • 6.10.3. Product Benchmarking
    • 6.10.4. Strategic Initiatives

List of Tables

  • 1. Glucose Biosensors - Industry Snapshot & Key Buying Criteria, 2012 - 2022
  • 2. Global glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million)
  • 3. Global glucose biosensors market, by region, 2012 - 2022 (USD Million)
  • 4. Glucose Biosensors - Key Market Driver Analysis
  • 5. Glucose Biosensors - Key Market Restraint Analysis
  • 6. North America glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million)
  • 7. U.S. glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million)
  • 8. Canada glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million)
  • 9. Europe glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million)
  • 10. Germany glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million)
  • 11. U.K. glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million)
  • 12. Rest of Europe glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million)
  • 13. Asia Pacific glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million)
  • 14. China glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million)
  • 15. India glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million)
  • 16. Rest of Asia Pacific glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million)
  • 17. Latin America glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million)
  • 18. Brazil glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million)
  • 19. Mexico glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million)
  • 20. Rest of Latin America glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million)
  • 21. MEA glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million)
  • 22. South Africa glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million)
  • 23. Saudi Arabia glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million)
  • 24. Rest of MEA glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million)

List of Figures

  • 1. Global glucose biosensors: Market segmentation
  • 2. Global glucose biosensors, 2012 - 2022 (USD Million)
  • 3. Diabetes prevalence of top 10 countries in 2013 in the age group of 20 to 79 years (million)
  • 4. Global glucose biosensors market: Industry trend analysis
  • 5. Global glucose biosensors market: PESTEL analysis
  • 6. Global glucose biosensors market: Porter's analysis
  • 7. Glucose biosensors company market share, 2014
  • 8. Key Opportunities Prioritized
  • 9. Glucose biosensors market revenue share by end-user application, 2014 & 2022
  • 10. Hospitals glucose biosensors market revenue, 2012 to 2022 (USD Million)
  • 11. Homecare diagnostics glucose biosensors market revenue, 2012 to 2022 (USD Million)
  • 12. Others market revenue, 2012 to 2022 (USD Million)
  • 13. Glucose biosensors market share, by region, 2014 & 2022
Back to Top